Sweden· SE-20180308000040
XELJANZ 11 mg Depottablett
A medicinal product containing tofacitinib, registered in Sweden by Pfizer Europe MA EEIG.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Tofacitinib
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20180308000040
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tofacitinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesTofacitinibAjanta Pharma USA Inc.
- CzechiaXELJANZPfizer Europe MA EEIG, Bruxelles
- CanadaTARO-TOFACITINIB XRTARO PHARMACEUTICALS INC
- NorwayXeljanzPfizer
- FinlandXeljanzPfizer Europe MA EEIG
- IcelandXELJANZPfizer Europe MA EEIG*
- NetherlandsXeljanz 11 mg, tablet met verlengde afgiftePfizer Europe MA EEIG
- PolandXeljanzPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Tofacitinib Devatis, Tofacitinib Stada
- Bulgaria · Tофацитиниб Devatis
- Denmark · Tofacitinib Accord, Tofacitinib Newbury
- Spain · Tofacitinib Stada
- Finland · Tofacitinib Devatis, Tofacitinib Stada
- France · Tofacitinib Stada
- United Kingdom (Northern Ireland) · Tofacitinib Amarox, Tofacitinib Brown & Burk Uk
- Croatia · Tofacitinib Accord, Tofacitinib Stada
- Iceland · Xeljanz
- Liechtenstein · Xeljanz
- Malta · Tofacitinib Stada
- Netherlands · Tofacitinib Devatis, Tofacitinib Stada
- Norway · Tofacitinib Accord, Tofacitinib Devatis
- Portugal · Tofacitinib Bluepharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6510aac0-0ee3-495c-b0dc-fefe9289d010 GET /v1/drugs/6510aac0-0ee3-495c-b0dc-fefe9289d010?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20180308000040",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20180308000040",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/xeljanz-epar-product-information_sv.pdf"
}See everything about tofacitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.